Concepedia

Yuquan Lin

YL

Statistics

Publications

4

Citations

113

H-Index

4

Active since

2012

Affiliations

National Cancer Institute(Current)

Fox Chase Cancer Center

National Institutes of Health

Yuquan Lin is an author at National Cancer Institute specializing in pharmacology, molecular oncology, and oncology.

ORCID

Publications per year

2012–2021

4

Publications

4

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

Takashi Ishio, Sarvesh Kumar, Joji Shimono et al. · Blood · 2021 · 40 citations · Full text

, , +17

Therapeutic effects of a novel tylophorine analog, NK‐007, on collagen‐induced arthritis through suppressing tumor necrosis factor α production and Th17 cell differentiation

Ti Wen, Yangguang Li, Meng Wu et al. · Arthritis & Rheumatism · 2012 · 34 citations

, , +17

A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models

Wei Wei, Yuquan Lin, Zhihui Song et al. · Clinical Cancer Research · 2020 · 27 citations · Full text

, , +13

Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia

Anusara Daenthanasanmak, Yuquan Lin, Meili Zhang et al. · Translational Oncology · 2020 · 12 citations · Full text

, , +16

1–4 of 4